APO RESEARCH · REPORT
Xylobiose
Xylobiose is a glycosylxylose that is D-xylopyranose having a beta-D-xylopyranosyl residue attached at position 4 via a glycosidic bond. It has a role as a bacterial metabolite.
Product & engineering
Understand the product.
Xylobiose is a glycosylxylose that is D-xylopyranose having a beta-D-xylopyranosyl residue attached at position 4 via a glycosidic bond. It has a role as a bacterial metabolite.
Selected research
Industry Growth & Trends
Global Xylobiose Industry Growth and Trends Forecast to 2032
Market perspective
Xylobiose is a glycosylxylose that is D-xylopyranose having a beta-D-xylopyranosyl residue attached at position 4 via a glycosidic bond. It has a role as a bacterial metabolite.
TCI, Qingdao BZ Oligo Biotech, Dalian GlycoBio and MilliporeSigma are the world's leading players, and the industry is highly concentrated. TCI is considered to be the leader in this industry, with TCI occupying 34% of the market in 2018. The Major regions to produce Xylobiose films are China, Japan, USA and UK, which accounting for about 85.8% of production in total. Asia Pacific is the largest consumption region (market share 37.98%). The application of Xylobiose is scientific research and industrial application. Scientific research is the major application, which accounts for more than 90% of market share.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Xylobiose market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Xylobiose market size, estimates, and forecasts are presented in terms of sales volume (mg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Xylobiose market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Xylobiose.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Xylobiose market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Xylobiose Market by Company
TCI
Qingdao BZ Oligo Biotech
Dalian GlycoBio
MilliporeSigma
BOC Sciences
CarboMer
Carbosynth
FUJIFILM Wako Pure Chemical
Xylobiose Segment by Type
Purity≥98%
Purity ≥90%
Xylobiose Segment by Application
Scientific Research
Industrial Application
Xylobiose Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Xylobiose market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Xylobiose and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Xylobiose.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Xylobiose manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Xylobiose in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity≥98%
- Purity ≥90%
Applications
- Scientific Research
- Industrial Application
Companies covered
- TCI
- Qingdao BZ Oligo Biotech
- Dalian GlycoBio
- MilliporeSigma
- BOC Sciences
- CarboMer
- Carbosynth
- FUJIFILM Wako Pure Chemical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Xylobiose Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Xylobiose Sales Estimates and Forecasts (2021-2032)
- 1.3 Xylobiose Market by Type
- 1.3.1 Purity≥98%
- 1.3.2 Purity ≥90%
- 1.4 Global Xylobiose Market Size by Type
- 1.4.1 Global Xylobiose Market Size Overview by Type (2021-2032)
- 1.4.2 Global Xylobiose Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Xylobiose Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Xylobiose Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Xylobiose Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Xylobiose Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Xylobiose Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Xylobiose Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Xylobiose Industry Trends
- 2.2 Xylobiose Industry Drivers
- 2.3 Xylobiose Industry Opportunities and Challenges
- 2.4 Xylobiose Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Xylobiose Revenue (2021-2026)
- 3.2 Global Top Players by Xylobiose Sales (2021-2026)
- 3.3 Global Top Players by Xylobiose Price (2021-2026)
- 3.4 Global Xylobiose Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Xylobiose Major Company Production Sites & Headquarters
- 3.6 Global Xylobiose Company, Product Type & Application
- 3.7 Global Xylobiose Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Xylobiose Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Xylobiose Players Market Share by Revenue in 2025
- 3.8.3 2025 Xylobiose Tier 1, Tier 2, and Tier 3
4 Xylobiose Regional Status and Outlook
- 4.1 Global Xylobiose Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Xylobiose Historic Market Size by Region
- 4.2.1 Global Xylobiose Sales in Volume by Region (2021-2026)
- 4.2.2 Global Xylobiose Sales in Value by Region (2021-2026)
- 4.2.3 Global Xylobiose Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Xylobiose Forecasted Market Size by Region
- 4.3.1 Global Xylobiose Sales in Volume by Region (2027-2032)
- 4.3.2 Global Xylobiose Sales in Value by Region (2027-2032)
- 4.3.3 Global Xylobiose Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Xylobiose by Application
- 5.1 Xylobiose Market by Application
- 5.1.1 Scientific Research
- 5.1.2 Industrial Application
- 5.2 Global Xylobiose Market Size by Application
- 5.2.1 Global Xylobiose Market Size Overview by Application (2021-2032)
- 5.2.2 Global Xylobiose Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Xylobiose Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Xylobiose Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Xylobiose Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Xylobiose Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Xylobiose Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Xylobiose Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 TCI
- 6.1.1 TCI Company Information
- 6.1.2 TCI Business Overview
- 6.1.3 TCI Xylobiose Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 TCI Xylobiose Product Portfolio
- 6.1.5 TCI Recent Developments
- 6.2 Qingdao BZ Oligo Biotech
- 6.2.1 Qingdao BZ Oligo Biotech Company Information
- 6.2.2 Qingdao BZ Oligo Biotech Business Overview
- 6.2.3 Qingdao BZ Oligo Biotech Xylobiose Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Qingdao BZ Oligo Biotech Xylobiose Product Portfolio
- 6.2.5 Qingdao BZ Oligo Biotech Recent Developments
- 6.3 Dalian GlycoBio
- 6.3.1 Dalian GlycoBio Company Information
- 6.3.2 Dalian GlycoBio Business Overview
- 6.3.3 Dalian GlycoBio Xylobiose Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Dalian GlycoBio Xylobiose Product Portfolio
- 6.3.5 Dalian GlycoBio Recent Developments
- 6.4 MilliporeSigma
- 6.4.1 MilliporeSigma Company Information
- 6.4.2 MilliporeSigma Business Overview
- 6.4.3 MilliporeSigma Xylobiose Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 MilliporeSigma Xylobiose Product Portfolio
- 6.4.5 MilliporeSigma Recent Developments
- 6.5 BOC Sciences
- 6.5.1 BOC Sciences Company Information
- 6.5.2 BOC Sciences Business Overview
- 6.5.3 BOC Sciences Xylobiose Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 BOC Sciences Xylobiose Product Portfolio
- 6.5.5 BOC Sciences Recent Developments
- 6.6 CarboMer
- 6.6.1 CarboMer Company Information
- 6.6.2 CarboMer Business Overview
- 6.6.3 CarboMer Xylobiose Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 CarboMer Xylobiose Product Portfolio
- 6.6.5 CarboMer Recent Developments
- 6.7 Carbosynth
- 6.7.1 Carbosynth Company Information
- 6.7.2 Carbosynth Business Overview
- 6.7.3 Carbosynth Xylobiose Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Carbosynth Xylobiose Product Portfolio
- 6.7.5 Carbosynth Recent Developments
- 6.8 FUJIFILM Wako Pure Chemical
- 6.8.1 FUJIFILM Wako Pure Chemical Company Information
- 6.8.2 FUJIFILM Wako Pure Chemical Business Overview
- 6.8.3 FUJIFILM Wako Pure Chemical Xylobiose Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 FUJIFILM Wako Pure Chemical Xylobiose Product Portfolio
- 6.8.5 FUJIFILM Wako Pure Chemical Recent Developments
7 North America by Country
- 7.1 North America Xylobiose Sales by Country
- 7.1.1 North America Xylobiose Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Xylobiose Sales by Country (2021-2026)
- 7.1.3 North America Xylobiose Sales Forecast by Country (2027-2032)
- 7.2 North America Xylobiose Market Size by Country
- 7.2.1 North America Xylobiose Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Xylobiose Market Size by Country (2021-2026)
- 7.2.3 North America Xylobiose Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Xylobiose Sales by Country
- 8.1.1 Europe Xylobiose Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Xylobiose Sales by Country (2021-2026)
- 8.1.3 Europe Xylobiose Sales Forecast by Country (2027-2032)
- 8.2 Europe Xylobiose Market Size by Country
- 8.2.1 Europe Xylobiose Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Xylobiose Market Size by Country (2021-2026)
- 8.2.3 Europe Xylobiose Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Xylobiose Sales by Country
- 9.1.1 Asia-Pacific Xylobiose Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Xylobiose Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Xylobiose Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Xylobiose Market Size by Country
- 9.2.1 Asia-Pacific Xylobiose Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Xylobiose Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Xylobiose Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Xylobiose Sales by Country
- 10.1.1 South America Xylobiose Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Xylobiose Sales by Country (2021-2026)
- 10.1.3 South America Xylobiose Sales Forecast by Country (2027-2032)
- 10.2 South America Xylobiose Market Size by Country
- 10.2.1 South America Xylobiose Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Xylobiose Market Size by Country (2021-2026)
- 10.2.3 South America Xylobiose Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Xylobiose Sales by Country
- 11.1.1 Middle East and Africa Xylobiose Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Xylobiose Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Xylobiose Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Xylobiose Market Size by Country
- 11.2.1 Middle East and Africa Xylobiose Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Xylobiose Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Xylobiose Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Xylobiose Value Chain Analysis
- 12.1.1 Xylobiose Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Xylobiose Production Mode & Process
- 12.2 Xylobiose Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Xylobiose Distributors
- 12.2.3 Xylobiose Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst